Pilot Study Investigating the Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer
Phase of Trial: Phase I
Latest Information Update: 12 Apr 2017
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Breast cancer; Head and neck cancer; Prostate cancer
- Focus Diagnostic use
- 07 Apr 2017 Status changed from active, no longer recruiting to completed.
- 04 May 2016 Planned End Date changed from 1 Apr 2016 to 1 Apr 2017.
- 04 May 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Apr 2017.